Complete cure and adverse events for terbinafine vs placebo
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
Terbinafine leads to higher clinical cure compared with placebo (high certainty).
Terbinafine leads to higher mycological cure compared with placebo (high certainty).
Terbinafine showed no clear difference in adverse events compared with placebo (moderate certainty).
Terbinafine may leads to lower recurrence rate compared with placebo (low certainty).
It is very uncertain whether combination terbinafine plus azole changes clinical cure compared with terbinafine monotherapy (very low certainty).
It is very uncertain whether combination terbinafine plus azole changes mycological cure compared with terbinafine monotherapy (very low certainty).
Combination terbinafine plus azole showed no clear difference in adverse events compared with terbinafine monotherapy (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.